vs
Avantor, Inc.（AVTR）とCore & Main, Inc.（CNM）の財務データ比較。上の社名をクリックして会社を切り替えられます
Core & Main, Inc.の直近四半期売上が大きい（$2.1B vs $1.7B、Avantor, Inc.の約1.2倍）。Core & Main, Inc.の純利益率が高く（6.6% vs 3.1%、差は3.5%）。Core & Main, Inc.の前年同期比売上増加率が高い（0.0% vs -1.4%）。Core & Main, Inc.の直近四半期フリーキャッシュフローが多い（$263.0M vs $117.2M）。過去8四半期でCore & Main, Inc.の売上複合成長率が高い（19.7% vs -0.5%）
アバンター社は米国ペンシルベニア州ラドノーに本社を置くバイオテクノロジー・化学・医薬品企業です。1904年にJ.T.ベイカーとして創業し2010年に現社名に変更、2019年にNY証券取引所に上場し、証券コードは「AVTR」で、世界中のライフサイエンス分野の顧客に製品を提供しています。
Core & Main, Inc.は米国ミズーリ州セントルイスに本社を置く流通企業で、水道・廃水処理・雨水排水・防火関連製品を取り扱っています。米国49州に370の支店を構え、自治体、民間水道事業者、専門業者を含む6万人の顧客に22万5千種類の製品を販売しています。
AVTR vs CNM — 直接比較
損益計算書 — Q4 FY2025 vs Q3 FY2026
| 指標 | | |
|---|---|---|
| 売上 | $1.7B | $2.1B |
| 純利益 | $52.4M | $137.0M |
| 粗利率 | 31.5% | 27.2% |
| 営業利益率 | 7.6% | 10.7% |
| 純利益率 | 3.1% | 6.6% |
| 売上前年比 | -1.4% | 0.0% |
| 純利益前年比 | -89.5% | 0.0% |
| EPS（希薄化後） | $0.08 | $0.72 |
緑 = その指標でリード。会計年度がずれている場合は期間が異なる場合あり
8四半期 売上・利益トレンド
並べて比較する四半期履歴。決算期がずれていても暦四半期で整列
| Q4 25 | $1.7B | $2.1B | ||
| Q3 25 | $1.6B | $2.1B | ||
| Q2 25 | $1.7B | $1.9B | ||
| Q1 25 | $1.6B | $1.7B | ||
| Q4 24 | $1.7B | $2.0B | ||
| Q3 24 | $1.7B | $2.0B | ||
| Q2 24 | $1.7B | $1.7B | ||
| Q1 24 | $1.7B | $1.4B |
| Q4 25 | $52.4M | $137.0M | ||
| Q3 25 | $-711.8M | $134.0M | ||
| Q2 25 | $64.7M | $100.0M | ||
| Q1 25 | $64.5M | $64.0M | ||
| Q4 24 | $500.4M | $133.0M | ||
| Q3 24 | $57.8M | $119.0M | ||
| Q2 24 | $92.9M | $95.0M | ||
| Q1 24 | $60.4M | $63.0M |
| Q4 25 | 31.5% | 27.2% | ||
| Q3 25 | 32.4% | 26.8% | ||
| Q2 25 | 32.9% | 26.7% | ||
| Q1 25 | 33.8% | 26.6% | ||
| Q4 24 | 33.4% | 26.6% | ||
| Q3 24 | 32.9% | 26.4% | ||
| Q2 24 | 34.1% | 26.9% | ||
| Q1 24 | 34.0% | 26.7% |
| Q4 25 | 7.6% | 10.7% | ||
| Q3 25 | -40.0% | 10.2% | ||
| Q2 25 | 7.7% | 8.9% | ||
| Q1 25 | 9.3% | 7.3% | ||
| Q4 24 | 37.8% | 10.9% | ||
| Q3 24 | 7.3% | 10.4% | ||
| Q2 24 | 10.3% | 9.6% | ||
| Q1 24 | 8.7% | 8.1% |
| Q4 25 | 3.1% | 6.6% | ||
| Q3 25 | -43.8% | 6.4% | ||
| Q2 25 | 3.8% | 5.2% | ||
| Q1 25 | 4.1% | 3.8% | ||
| Q4 24 | 29.7% | 6.5% | ||
| Q3 24 | 3.4% | 6.1% | ||
| Q2 24 | 5.5% | 5.5% | ||
| Q1 24 | 3.6% | 4.4% |
| Q4 25 | $0.08 | $0.72 | ||
| Q3 25 | $-1.04 | $0.70 | ||
| Q2 25 | $0.09 | $0.52 | ||
| Q1 25 | $0.09 | $0.34 | ||
| Q4 24 | $0.73 | $0.69 | ||
| Q3 24 | $0.08 | $0.61 | ||
| Q2 24 | $0.14 | $0.49 | ||
| Q1 24 | $0.09 | $0.34 |
貸借対照表と財務力
直近四半期の流動性・レバレッジ・純資産のスナップショット
| 指標 | | |
|---|---|---|
| 現金・短期投資手元流動性 | $365.4M | $89.0M |
| 総負債低いほど良い | $3.9B | — |
| 株主資本純資産 | $5.6B | $2.0B |
| 総資産 | $11.8B | $6.3B |
| 負債/資本比率低いほどレバレッジが低い | 0.71× | — |
8四半期トレンド — 暦四半期で整列
| Q4 25 | $365.4M | $89.0M | ||
| Q3 25 | $251.9M | $25.0M | ||
| Q2 25 | $449.4M | $8.0M | ||
| Q1 25 | $315.7M | $8.0M | ||
| Q4 24 | $261.9M | $10.0M | ||
| Q3 24 | $285.3M | $13.0M | ||
| Q2 24 | $272.6M | $30.0M | ||
| Q1 24 | $234.9M | $1.0M |
| Q4 25 | $3.9B | — | ||
| Q3 25 | $3.9B | — | ||
| Q2 25 | $4.2B | — | ||
| Q1 25 | $4.1B | — | ||
| Q4 24 | $4.1B | — | ||
| Q3 24 | $4.9B | — | ||
| Q2 24 | $5.1B | — | ||
| Q1 24 | $5.3B | — |
| Q4 25 | $5.6B | $2.0B | ||
| Q3 25 | $5.6B | $1.9B | ||
| Q2 25 | $6.3B | $1.7B | ||
| Q1 25 | $6.1B | $1.7B | ||
| Q4 24 | $6.0B | $1.7B | ||
| Q3 24 | $5.6B | $1.6B | ||
| Q2 24 | $5.4B | $1.6B | ||
| Q1 24 | $5.3B | $1.5B |
| Q4 25 | $11.8B | $6.3B | ||
| Q3 25 | $11.7B | $6.3B | ||
| Q2 25 | $12.8B | $6.3B | ||
| Q1 25 | $12.3B | $5.9B | ||
| Q4 24 | $12.1B | $6.2B | ||
| Q3 24 | $12.8B | $6.1B | ||
| Q2 24 | $12.7B | $6.0B | ||
| Q1 24 | $12.8B | $5.1B |
| Q4 25 | 0.71× | — | ||
| Q3 25 | 0.69× | — | ||
| Q2 25 | 0.67× | — | ||
| Q1 25 | 0.67× | — | ||
| Q4 24 | 0.68× | — | ||
| Q3 24 | 0.89× | — | ||
| Q2 24 | 0.94× | — | ||
| Q1 24 | 1.00× | — |
キャッシュフローと資本効率
再投資後に実際に生み出すキャッシュ。純利益より操作が難しい
| 指標 | | |
|---|---|---|
| 営業キャッシュフロー直近四半期 | $152.7M | $271.0M |
| フリーキャッシュフロー営業CF - 設備投資 | $117.2M | $263.0M |
| FCFマージンFCF / 売上 | 7.0% | 12.8% |
| 設備投資強度設備投資 / 売上 | 2.1% | 0.4% |
| キャッシュ転換率営業CF / 純利益 | 2.91× | 1.98× |
| 直近12ヶ月FCF直近4四半期 | $495.0M | $575.0M |
8四半期トレンド — 暦四半期で整列
| Q4 25 | $152.7M | $271.0M | ||
| Q3 25 | $207.4M | $34.0M | ||
| Q2 25 | $154.4M | $77.0M | ||
| Q1 25 | $109.3M | $235.0M | ||
| Q4 24 | $173.3M | $260.0M | ||
| Q3 24 | $244.8M | $48.0M | ||
| Q2 24 | $281.1M | $78.0M | ||
| Q1 24 | $141.6M | $294.0M |
| Q4 25 | $117.2M | $263.0M | ||
| Q3 25 | $171.7M | $24.0M | ||
| Q2 25 | $124.8M | $64.0M | ||
| Q1 25 | $81.3M | $224.0M | ||
| Q4 24 | $145.8M | $252.0M | ||
| Q3 24 | $204.0M | $39.0M | ||
| Q2 24 | $235.3M | $71.0M | ||
| Q1 24 | $106.9M | $289.0M |
| Q4 25 | 7.0% | 12.8% | ||
| Q3 25 | 10.6% | 1.1% | ||
| Q2 25 | 7.4% | 3.3% | ||
| Q1 25 | 5.1% | 13.2% | ||
| Q4 24 | 8.6% | 12.4% | ||
| Q3 24 | 11.9% | 2.0% | ||
| Q2 24 | 13.8% | 4.1% | ||
| Q1 24 | 6.4% | 20.1% |
| Q4 25 | 2.1% | 0.4% | ||
| Q3 25 | 2.2% | 0.5% | ||
| Q2 25 | 1.8% | 0.7% | ||
| Q1 25 | 1.8% | 0.6% | ||
| Q4 24 | 1.6% | 0.4% | ||
| Q3 24 | 2.4% | 0.5% | ||
| Q2 24 | 2.7% | 0.4% | ||
| Q1 24 | 2.1% | 0.3% |
| Q4 25 | 2.91× | 1.98× | ||
| Q3 25 | — | 0.25× | ||
| Q2 25 | 2.39× | 0.77× | ||
| Q1 25 | 1.69× | 3.67× | ||
| Q4 24 | 0.35× | 1.95× | ||
| Q3 24 | 4.24× | 0.40× | ||
| Q2 24 | 3.03× | 0.82× | ||
| Q1 24 | 2.34× | 4.67× |
財務フロー比較
売上 → 粗利 → 営業利益 → 純利益のサンキー図
セグメント別売上内訳
AVTR
| Laboratory Solutions Segment | $1.1B | 67% |
| Bioscience Production Segment | $547.5M | 33% |
CNM
| Pipes Valves And Fitting Products | $1.4B | 67% |
| Storm Drainage Products | $333.0M | 16% |
| Meter Products | $195.0M | 9% |
| Fire Protection Products | $152.0M | 7% |
